• In late June 2026, Liquidia Corporation was removed from several Russell indices, including the Russell 3000E and Russell Microcap benchmarks, following the latest reconstitution.
• This broad index removal can matter for investors because funds tracking those benchmarks may adjust their holdings, potentially altering trading liquidity and ownership mix for Liquidia.
• We’ll now examine how Liquidia’s removal from multiple Russell indices interacts with its existing growth-focused investment narrative and risk profile.

Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

Liquidia Investment Narrative Recap

To own Liquidia, you have to believe YUTREPIA can sustain its current commercial momentum while the company manages execution risk around manufacturing expansion and pipeline investment. The recent removal from several Russell indices does not change the near term focus on payer access, real world ASCENT data and capacity build out, although it may modestly affect trading liquidity rather than the core business story right now.

The most relevant recent update alongside the index changes is Liquidia’s strong Q1 2026 earnings, with revenue of US$132.87 million and net income of US$52.86 million. Those results highlight how quickly YUTREPIA has shifted Liquidia into profitability, which ties directly into the main catalyst many shareholders are watching: whether early prescription strength and high gross margins can translate into durable earnings as voucher programs taper and new manufacturing capacity comes online.

Yet even with strong recent results, investors should be aware that payer terms and gross to net dynamics could still...

Liquidia's narrative projects $1.4 billion revenue and $665.8 million earnings by 2029. This implies 68.6% yearly revenue growth and an earnings increase of about $643.5 million from $22.3 million today.

Uncover how Liquidia's forecasts yield a $72.38 fair value, a 8% downside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts were already cautious, assuming revenue of about US$555.6 million and earnings of roughly US$23.4 million by 2028, which contrasts sharply with more optimistic views on YUTREPIA’s trajectory and could look very different once index changes and new data points are fully reflected.

Explore 5 other fair value estimates on Liquidia - why the stock might be worth over 4x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Liquidia research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Liquidia research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Liquidia's overall financial health at a glance.

Curious About Other Options?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Rare earth metals are the new gold rush. Find out which 31 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.